Codexis (id:8156 CDXS)
4.61 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 3:20:41 PM)
Exchange closed, opens in 18 hours 9 minutes
About Codexis
Market Capitalization 315.75M
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
| Headquarters (address) |
200 Penobscot Drive Redwood City 94063 CA United States |
| Phone | 650 421 8100 |
| Website | https://www.codexis.com |
| Employees | 174 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | CDXS |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 1.85 - 4.91 |
| Market Capitalization | 315.75M |
| P/E trailing | -4.12 |
| P/E forward | -5.62 |
| Price/Sale | 4.90 |
| Price/Book | 4.30 |
| Beta | 2.07 |
| EPS | -0.880 |
| EPS United States (ID:6, base:3402) | 24.22 |